<DOC>
	<DOCNO>NCT02232919</DOCNO>
	<brief_summary>The burden morbid obesity circulatory , endocrine , locomotor system , well psychological effect relate health-care cost , well establish medical literature . Lifestyle dietary pattern remain critical factor modulate long-term weight control morbidly obese individual ( bodymass index â‰¥ 40 ) . Various dietary , pharmacological , behavioral intervention largely fail therapy , often necessitate surgery last treatment option . Long term result bariatric surgery suggest sustain substantial weight loss decrease morbidity relate obesity secondary complication diabetes type 2 cancer , enhance role surgery morbidly obese subject . However adverse effect bariatric surgery considerable impact quality life . Its long-term failure rate complication call novel effective long-term therapy , neurosurgical intervention . The investigator propose enhance target capability feasibility study low frequency electrical stimulation use VMH-DBS ( ventromedial hypothalamic ) six morbidly obese patient . After successful targeting , DBS stimulation parameter systematically evaluate individually optimize three-month interval one-year stimulation period . Detailed record side effect , weight change , food intake pattern , metabolic change , behavioral evaluation obtain throughout study .</brief_summary>
	<brief_title>Deep Brain Stimulation Human Morbid Obesity</brief_title>
	<detailed_description>Neuromodulation metabolism feed behavior hand use modern system deep brain stimulation ( DBS ) . It constitute minimally invasive approach challenge patient . The surgical procedure reversible proven acceptable side effect frail population Parkinson 's disease patient [ Gorgulho , Hemorrhage Infection ] . Improvement functional stereotactic surgery method necessary however challenge implant DBS electrode hypothalamus . Recently , case report patient DBS implant hypothalamus treatment morbid obesity report side effect related memory appear literature . The author use side effect finding suggest location implant site treatment Alzheimer 's disease . This illustrate need betterment technique target DBS surgery , especially target locate highly functional structure , hypothalamus .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>1 . Body Mass Index [ BMI ] &gt; 40 kg/m2 . BMI definition = weight [ Kg ] / height [ ] 2 2 . Failed diet , exercise , behavior , pharmacotherapy control body weight . 1 . Cancer require treatment past five year , exception cancer cure , opinion investigator , carry good prognosis [ example , non melanoma skin cancer ] . 2 . Infectious disease [ e.g. , HIV active tuberculosis ] . 3 . Cardiovascular disease : . Hospitalization treatment heart disease past 6 month . ii . New York Heart Association Functional Class &gt; 2 . iii . Left bundle branch block EKG . iv . Third degree atrioventricular block EKG . v. Uncontrolled hypertension [ average systolic blood pressure &gt; 160 mmHg diastolic blood pressure &gt; 95 mmHg screen visit ] . vi . Pulse rate &gt; 95 beat per minute screen visit . vii . Total serum cholesterol &gt; 300 mg/dL . viii . Stroke transient ischemic attack past 6 month . 4 . Gastrointestinal disease : . Chronic hepatitis cirrhosis . ii . Episode alcoholic hepatitis alcoholic pancreatitis . iii . Inflammatory bowel disease require treatment past year . iv . Recent significant abdominal surgery [ e.g. , gastrectomy gastric bypass ] . 5 . Renal disease : i. Serum creatinine &gt; 1.5 mg/dL . ii . Urine protein &gt; 2+ dipstick screen 24hour urinary excretion albumin &gt; 500 mg/day . 6 . Lung disease : . Chronic obstructive airway disease asthma require daily therapy . ii . Use home oxygen . 7 . Endocrine disease : i. Diabetes mellitus . ii . Hyperlipidemia triacylglycerol &gt; 500 mg/dL . iii . Hypothyroidism , hyperthyroidism . iv . Hypopituitarism . v. Hypogonadism . 8 . Psychological Disease : . Major clinical depression . ii . Active psychiatric disorder . iii . Schizophrenia . 9 . Hematology . Anemia [ hematocrit &lt; 36.0 % ] . ii . Bleeding disorder , thrombocytopenia , thrombocytosis . 10 . Conditions behavior likely affect conduct study : . Unable unwilling give inform consent . ii . Unable communicate clinic staff . iii . Weight loss &gt; 10 % past 6 month . iv . Unable walk 0.25 mile 10 minute . v. Behavioral disorder , opinion investigator , would impede conduct study . vi . Excessive alcohol intake , use illicit drug . 11 . Conditions related medication : i. Psychoactive agent . ii . Monoamine oxidase inhibitor [ e.g. , phenelzine , procarbazine , selegiline , furazolidone ] . iii . Antidepressants [ e.g. , lithium , fluoxetine , sertraline , nefazodone , paroxetine , venlafaxine ] . iv . Any medication , opinion investigator , may pose harm subject . 12 . Seizure disorder . 13 . Receiving anticoagulation medication likely need anticoagulation foreseeable future . 14 . Subject surgical candidate . 15 . Lack social support . 16 . Inability comply test followup visit requirement define Study Protocol . 17 . Subject another implanted device metallic object [ e.g. , cardiac demand pacemaker , aneurysm clip , cochlear implant , spinal cord stimulator , etc ] . 18 . Subject medical condition might require repeat MRIs . 19 . Subject concurrent infection . 20 . Subject medical condition contraindicate chronically implant device .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Deep Brain Stimulation</keyword>
</DOC>